UK benefiting from German reform?
Healthcare reform and cost containment affecting the rest of Europe are making the UK increasingly attractive to the branded pharmaceutical sector.
Archives for September 21, 2003
GSK sweetens Montrose plant closure
Pharmaceutical major GlaxoSmithKline has set aside £1 million (€1.4m) to soften the blow of selling its bulk active ingredient manufacturing facility in Montrose.
Plant production for cancer protein
Dow Chemical has entered into an agreement to manufacture a potential drug for cancer in transgenic plants. The deal, with Sunol Molecular, covers production of the protein in plants and a comparison with a version grown in mammalian cell culture.
Specialist pharma construction
Skanska's US subsidiary sets up dedicated group aimed at designing and building FDA-compliant facilities for the pharma/biotech industries.
Novo expands engineering services in Sweden
Novo Nordisk Engineering, a consultancy firm operating as a subsidiary of Danish pharmaceutical company Novo Nordisk, has opened an office in Sweden.